)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
AnteoTech
AnteoTech (ADO) investor relations material
AnteoTech AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary10 Nov, 2026
Financial performance review
FY2026 sales revenue was A$467,589, versus A$968,878 in FY2025 and A$460,397 in FY2024; FY2025 included an additional SII payment of A$276,863.
A further A$134,138 SII sale completed on 7 July 2026 is being recognised in FY2027.
FY2026 expenses, excluding depreciation, amortisation and share-based payments, were A$6,857,881, versus A$8,451,114 in FY2025 and A$10,892,231 in FY2024.
Board and executive committee updates
Glenda McLoughlin serves as Non-Executive Chair, with investment banking, commercial advisory, ASX founding, energy and infrastructure experience.
Dr. Geoff Cumming serves as Non-Executive Director; his experience spans research, sales, marketing and executive roles at Roche, and he also sits on the INOVIQ Ltd board.
Merrill Gray is Managing Director and CEO, with experience in energy, batteries, hydrogen and renewables.
Corporate governance
At 4 November 2026, issued shares totaled 3,265.1 million; unlisted options totaled 233.5 million, with 7% expiring in 2026 and 65% in 2028.
The top 20 shareholders held 20% of issued shares; market capitalisation was A$52 million as at 3 November 2026.
Cash, including term deposits, totaled A$11.0 million as at 30 September 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AnteoTech
- Commercial execution advanced, with A$11.0m cash supporting the sales-conversion push.ADO
Q1 2027 TU - AnteoBind’s growth plan combines four-platform reach with supply and co-development partnerships.ADOInvestor presentation
- Net loss narrowed and total revenue reached $3.13M as commercialization advanced in FY2026.ADOH2 2026
- Ultranode™ 95 validated for drones, new products launched, and cash reserves rose to A$11.2M.ADOQ4 2026 TU
- Scaling high-silicon battery tech and diagnostics for global growth with strong market momentum.ADOInvestor presentation
- Record product evaluations and global partnerships drive growth in life sciences and batteries.ADOInvestor presentation
- Cash-rich, debt-free, with major product launches and global partnerships driving growth.ADOQ3 2026 TU
- Revenue up, loss down, first commercial sales and major contract secured; going concern risk flagged.ADOH2 2024
- Proprietary chemistry and AnteoBind NXT drive diagnostics growth and global expansion.ADONWR Virtual Healthcare Conference
AnteoTech
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
AnteoTech Limited is a technology company specializing in surface chemistry and nanomaterial solutions. It develops and commercializes products for applications in energy storage, diagnostics, and biotechnology. The company’s key offerings include lithium-ion battery additives to enhance performance and efficiency, as well as diagnostic solutions for medical and research applications. The company is headquartered in Brisbane, Australia, and its shares are listed on the ASX.